About
A private investor who writes his reasoning down.
I'm Marek Diko, a long-term investor from Slovakia. Not a fund, not an adviser: one person investing his own money and showing the work behind it.

Why I do this
Much of my research starts with one question: what needs to be built for AI to become useful on a much larger scale? The answer leads to semiconductors, data centres, electricity and the grid. That theme sits alongside ETFs, banks, established businesses and a small crypto position.
I share what I research because writing forces clarity. It makes me separate facts from opinions, notice what I don't know and stay calm when markets get loud.
What Longview is
Longview is the name of my research project: a way to organise portfolio research, check sources and track how each investment thesis develops over time. It supports the process; it does not remove uncertainty or investment risk.
Questions
Frequently asked.
Is this investment advice?
No. I share my own research and decisions for educational purposes. I don't know your situation, and nothing here is a recommendation to buy or sell anything.
Where can I see your actual portfolio?
On my public eToro profile. The holdings, risk score and track record there are calculated and verified by eToro, not by me.
How often do you publish?
One long-form article a week on Substack, short notes in between, and daily posts on eToro.
Do you get paid for anything here?
The research is free. The only commercial link is an eToro referral link, always marked as such: if you open an account through it, eToro may reward me. Nobody pays me to write about a company.
How can I reach you?
Comment on Substack or write to me on LinkedIn. Well-argued disagreement is especially welcome.
Free newsletter
Research notes, once a week, in your inbox.
What I read, what changed in my thinking and why. Written for people who invest for years, not days.
- One long-form article every week
- Short notes when something important happens
- Facts first, my view clearly separated
- No tips, no price targets, no hype